SmartZyme BioPharma
About:
SmartZyme is a medical technology company enabling a seamless leap to better performing glucose monitoring for people with diabetes.
Website: http://smzyme.com
Twitter/X: SmartZyme
Top Investors: OrbiMed, Virtus Inspire Ventures
Description:
Better Continuous Glucose Monitors with a Next-Generation Glucose Sensing Enzyme SmartZyme BioPharma, Inc. is a medical technology company enabling a seamless leap to better performing glucose monitoring for people with diabetes. The company is accelerating the integration of SmartZyme's next-generation glucose-sensing enzyme into continuous glucose monitoring devices. A next-generation enzyme means no more signal mediators for the most cost-effective manufacturing; no more hypoglycemic errors for a superior safety profile; and no more fingersticks for the best quality of life. SmartZyme is an OrbiMed portfolio company.
$8M
$1M to $10M
New York, New York, United States
2013-01-01
David Baram, Shilo Ben Zeev
11-50
2018-03-14
Private
© 2025 bioDAO.ai